IL17A and heart failure: Based on network pharmacology analysis and the subsequent enrichment analysis, our results suggested that Ginsenoside Rg3 may be used to treat heart failure via anti-inflammation effects, which potentially involved regulation of interleukin-8 production, regulation of immune effector process, positive regulation of IL-6 production, regulation of interleukin-8 production, positive regulation of immune effector process, cytokine receptor binding, cytokine activity, adipocytokine signaling pathway, and interleukin-17 signaling pathway.